NCT02499822 - REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial | Biotech Hunter

Enrollment

168

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 3, 2020

Study Completion Date

November 1, 2020

Conditions

HypertensionHigh Blood Pressure Variability

Interventions

DRUG

Nifedipine GITS

Commercially available drug formulations are used. Study medication will be assumed in a single morning (7-10 a.m.) administration per os.

DRUG

Ramipril

Commercially available drug formulations are used. Study medication will be assumed in a single morning (7-10 a.m.) administration per os.

Trial Locations (3)

Unknown

Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital Shanghai Institute of Hypertension, Shanghai Jiaotong University School of Medicine, Shanghai

Hypertension Center, Third University Department of Medicine, Sotiria Hospital, Athens

Istituto Auxologico Italiano, Milan